HERA commissioned feasibility study on stockpiling of antimicrobials against AMR published

  05 February 2023

HERA commissioned an AMR feasibility study on stockpiling, initiated as preparatory actions under the HERA incubator, and covering two key priority areas of HERA: the threat of antimicrobial resistance (AMR) and stockpiling efforts for medical countermeasures.

The study covers and elaborates on:

  • Identification of antimicrobials with critical need for undisrupted access
  • Analysis of supply chain vulnerabilities for the selected antimicrobials
  • Review of existing antimicrobial stockpiling systems at EU and global level
  • Identification and assessment of options for stockpiling of antimicrobials at EU level (physical vs virtual alternatives)

The study has been carried out in two phases, each delivering a specific report.

Further reading: European Commission
Author(s): European Commission
Effective Surveillance  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
Popup Plugin